Legend Biotech (LEGN) EPS (Basic) (QoQ) (2019 - 2025)
Legend Biotech (LEGN) EPS (Basic) (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - |
| 10 | Legend Biotech | 11.04 Bn | 10.14 Bn | 242.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 227,600,997.22% |
| Sep 30, 2025 | -67.65% |
| Jun 30, 2025 | 1,350.84% |
| Mar 31, 2025 | 100.00% |
| Dec 31, 2024 | -1,755,687,989.23% |
| Sep 30, 2024 | 580.00% |
| Jun 30, 2024 | 407.44% |
| Mar 31, 2024 | 100.00% |
| Dec 31, 2023 | -5,657,242,118.01% |
| Sep 30, 2023 | -87.20% |
| Jun 30, 2023 | 3,475.17% |
| Mar 31, 2023 | 20.19% |
| Dec 31, 2022 | -100.16% |
| Sep 30, 2022 | -100.00% |
| Jun 30, 2022 | 7,270,360,252.37% |
| Mar 31, 2022 | 100.00% |
| Dec 31, 2021 | 27.13% |
| Sep 30, 2021 | -100.16% |
| Jun 30, 2021 | 80,683.39% |
| Mar 31, 2021 | -38.91% |